The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy.
Brain malformation
Developmental delay
Human phenotype ontology
Lissencephaly
Microcephaly
TUBA1A
Tubulin
Tubulinopathy
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
11 02 2019
11 02 2019
Historique:
received:
17
10
2018
accepted:
03
02
2019
entrez:
13
2
2019
pubmed:
13
2
2019
medline:
20
4
2019
Statut:
epublish
Résumé
The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A. In three individuals with developmental delay we identified heterozygous de novo missense variants in TUBA1A using exome sequencing. While the c.1307G > A, p.(Gly436Asp) variant was novel, the two variants c.518C > T, p.(Pro173Leu) and c.641G > A, p.(Arg214His) were previously described. We compared the variable phenotype observed in these individuals with a carefully conducted review of the current literature and identified 166 individuals, 146 born and 20 fetuses with a TUBA1A variant. In 107 cases with available clinical information we standardized the reported phenotypes according to the Human Phenotype Ontology. The most commonly reported features were developmental delay (98%), anomalies of the corpus callosum (96%), microcephaly (76%) and lissencephaly (agyria-pachygyria) (70%), although reporting was incomplete in the different studies. We identified a total of 121 specific variants, including 15 recurrent ones. Missense variants cluster in the C-terminal region around the most commonly affected amino acid position Arg402 (13.3%). In a three-dimensional protein model, 38.6% of all disease-causing variants including those in the C-terminal region are predicted to affect the binding of microtubule-associated proteins or motor proteins. Genotype-phenotype analysis for recurrent variants showed an overrepresentation of certain clinical features. However, individuals with these variants are often reported in the same publication. With 166 individuals, we present the most comprehensive phenotypic and genotypic standardized synopsis for clinical interpretation of TUBA1A variants. Despite this considerable number, a detailed genotype-phenotype characterization is limited by large inter-study variability in reporting.
Sections du résumé
BACKGROUND
The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A.
RESULTS
In three individuals with developmental delay we identified heterozygous de novo missense variants in TUBA1A using exome sequencing. While the c.1307G > A, p.(Gly436Asp) variant was novel, the two variants c.518C > T, p.(Pro173Leu) and c.641G > A, p.(Arg214His) were previously described. We compared the variable phenotype observed in these individuals with a carefully conducted review of the current literature and identified 166 individuals, 146 born and 20 fetuses with a TUBA1A variant. In 107 cases with available clinical information we standardized the reported phenotypes according to the Human Phenotype Ontology. The most commonly reported features were developmental delay (98%), anomalies of the corpus callosum (96%), microcephaly (76%) and lissencephaly (agyria-pachygyria) (70%), although reporting was incomplete in the different studies. We identified a total of 121 specific variants, including 15 recurrent ones. Missense variants cluster in the C-terminal region around the most commonly affected amino acid position Arg402 (13.3%). In a three-dimensional protein model, 38.6% of all disease-causing variants including those in the C-terminal region are predicted to affect the binding of microtubule-associated proteins or motor proteins. Genotype-phenotype analysis for recurrent variants showed an overrepresentation of certain clinical features. However, individuals with these variants are often reported in the same publication.
CONCLUSIONS
With 166 individuals, we present the most comprehensive phenotypic and genotypic standardized synopsis for clinical interpretation of TUBA1A variants. Despite this considerable number, a detailed genotype-phenotype characterization is limited by large inter-study variability in reporting.
Identifiants
pubmed: 30744660
doi: 10.1186/s13023-019-1020-x
pii: 10.1186/s13023-019-1020-x
pmc: PMC6371496
doi:
Substances chimiques
TUBA1A protein, human
0
Tubulin
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
38Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : TH 896/3-4
Pays : International
Organisme : Interdisciplinary Centre for Clinical Research Erlangen
ID : F4
Pays : International
Organisme : ELAN Fond
ID : 14-08-06-1
Pays : International
Références
Genet Med. 2016 Sep;18(9):898-905
pubmed: 26795593
Genet Med. 2018 Jun;20(6):630-638
pubmed: 29758562
Curr Opin Genet Dev. 2011 Jun;21(3):286-94
pubmed: 21292473
Sci Rep. 2015 Oct 23;5:15165
pubmed: 26493046
Eur J Hum Genet. 2017 Dec;25(12):1364-1376
pubmed: 29158550
Brain. 2008 Sep;131(Pt 9):2304-20
pubmed: 18669490
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Neurology. 2011 Mar 15;76(11):988-92
pubmed: 21403111
Mol Biol Cell. 2017 Oct 15;28(21):2786-2801
pubmed: 28835377
Hum Mutat. 2013 Sep;34(9):E2393-402
pubmed: 23843252
Acta Neuropathol. 2010 Jun;119(6):779-89
pubmed: 20376468
Nat Genet. 2013 Jun;45(6):639-47
pubmed: 23603762
Genet Med. 2018 Nov;20(11):1354-1364
pubmed: 29671837
Brain Dev. 2018 Oct;40(9):819-823
pubmed: 29907476
Nature. 1998 Jan 8;391(6663):199-203
pubmed: 9428769
Am J Hum Genet. 2009 Nov;85(5):737-44
pubmed: 19896110
Am J Hum Genet. 2014 Apr 3;94(4):634-41
pubmed: 24702957
Structure. 2002 Oct;10(10):1317-28
pubmed: 12377118
Hum Mutat. 2011 May;32(5):557-63
pubmed: 21520333
Neurol Sci. 2014 May;35(5):801-3
pubmed: 24510153
Clin Genet. 2014 Feb;85(2):178-83
pubmed: 23495813
Hum Mol Genet. 2015 Sep 15;24(18):5313-25
pubmed: 26130693
Hum Mol Genet. 2010 Nov 15;19(22):4462-73
pubmed: 20829227
Pediatr Neurol. 2015 Nov;53(5):442-4
pubmed: 26294046
BMC Res Notes. 2014 Jul 22;7:465
pubmed: 25053001
Trends Genet. 2007 Dec;23(12):623-30
pubmed: 17997185
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nucleic Acids Res. 2017 Jan 4;45(D1):D804-D811
pubmed: 27907889
Clin Genet. 2008 Nov;74(5):425-33
pubmed: 18954413
J Child Neurol. 2012 Dec;27(12):1534-40
pubmed: 22408144
Nat Genet. 2009 Jun;41(6):746-52
pubmed: 19465910
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Eur Radiol. 2017 Dec;27(12):5080-5092
pubmed: 28677066
Brain Dev. 2013 Mar;35(3):274-9
pubmed: 22633752
J Biol Chem. 2016 Jun 17;291(25):12907-15
pubmed: 27129203
Mol Brain. 2016 Jul 19;9(1):70
pubmed: 27431206
Dev Med Child Neurol. 2014 Apr;56(4):354-60
pubmed: 24392928
Curr Opin Cell Biol. 2008 Feb;20(1):71-6
pubmed: 18226514
Neuron. 2014 Oct 22;84(2):292-309
pubmed: 25374356
Int J Mol Sci. 2017 Oct 29;18(11):
pubmed: 29109381
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nucleic Acids Res. 2017 Jan 4;45(D1):D865-D876
pubmed: 27899602
Eur J Hum Genet. 2013 Apr;21(4):381-5
pubmed: 22948023
Curr Opin Microbiol. 2003 Dec;6(6):634-40
pubmed: 14662361
Cell. 2007 Jan 12;128(1):45-57
pubmed: 17218254
Hum Mol Genet. 2010 Jul 15;19(14):2817-27
pubmed: 20466733
Science. 2018 Jun 15;360(6394):1242-1246
pubmed: 29748322
Eur J Paediatr Neurol. 2013 Jul;17(4):361-5
pubmed: 23317684
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Curr Opin Cell Biol. 1995 Feb;7(1):72-81
pubmed: 7755992
Brain. 2013 Feb;136(Pt 2):536-48
pubmed: 23361065
N Engl J Med. 2012 Nov 15;367(20):1921-9
pubmed: 23033978
EMBO J. 2006 Sep 20;25(18):4187-94
pubmed: 16946706
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Hum Mutat. 2008 Jan;29(1):6-13
pubmed: 18000842
J Med Genet. 2008 Oct;45(10):647-53
pubmed: 18728072
Birth Defects Res A Clin Mol Teratol. 2016 Jan;106(1):36-46
pubmed: 26663670
Pediatr Neurol. 2012 Feb;46(2):127-31
pubmed: 22264709
Hum Mutat. 2007 Nov;28(11):1055-64
pubmed: 17584854
Brain Dev. 2014 Feb;36(2):159-62
pubmed: 23528852
Eur J Hum Genet. 2018 Aug;26(8):1121-1131
pubmed: 29706646
Brain. 2014 Jun;137(Pt 6):1676-700
pubmed: 24860126
Nat Neurosci. 2016 Sep;19(9):1194-6
pubmed: 27479843
Neuron. 2015 Aug 5;87(3):492-506
pubmed: 26247859
Cell Rep. 2012 Dec 27;2(6):1554-62
pubmed: 23246003
Acta Neuropathol Commun. 2014 Jul 25;2:69
pubmed: 25059107
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Genet Med. 2016 Jul;18(7):678-85
pubmed: 26633545
Annu Rev Biophys Biomol Struct. 2001;30:397-420
pubmed: 11441808